LSTA · Lisata Therapeutics, Inc. · Exempt Offerings
$1.26
-0.21 (-14.29%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current business plan and existing capital resources, management has concluded that there is substantial doubt regarding our ability to continue as a going concern for a period of twelve months from the date of issuance of the accompanying consolidated financial statements.”View the 10-Q filed Aug 6, 2026
Market Cap
$14.24M
Shares
9.01M
Volume · Oct 5
90.75K
Avg daily vol (3M)
286.44K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-10-02 | New | Biotechnology | $351,903,103 | $351,903,103 | 06b |
| 2021-02-01 | New | Biotechnology | $25,000,000 | $25,000,000 | 06b |
| 2020-07-27 | New | Biotechnology | $1,999,994 | $1,999,994 | 06b |
| 2020-06-05 | New | Biotechnology | $2,150,002 | $2,150,002 | 06b |
| 2020-05-12 | New | Biotechnology | $2,432,437 | $2,432,437 | 06b |
Showing 1–5 of 5 filings